Video

Lymphoma and Biologics


 

Dr. Joel Gelfand discusses research concerning the use of biologics and lymphoma risk. Kerri Wachter of the Global Medical News Network (GMNN) reports from the American Academy of Dermatology's Academy 2009 meeting in Boston.

Recommended Reading

Novel agent more effective than standard therapy in NHL
MDedge Hematology and Oncology
Potential cause of R-CHOP failure ruled out
MDedge Hematology and Oncology
Most effective first-line therapy for T-PLL
MDedge Hematology and Oncology